BACK TO ALL REFERENCES
ASCERTAIN: More affordability and sustainability in innovative health tech
The ASCERTAIN project (Affordability and Sustainability improvements through new pricing, Cost-Effectiveness and Reimbursement models to Appraise iNnovative health technologies) aims to improve the affordability and sustainability of innovative health technologies.
€5 m
in funding
4
years
9
partners
Key numbers
About the project
The ASCERTAIN project addresses the need of patients, physicians, payers, regulators and manufacturers to improve the affordability and accessibility to innovative health technologies (including pharmaceuticals) in Europe. The project aims to improve the quality of care for cancer patients especially in Eastern Europe. If certain parts in the process can be accelerated, the project outcomes can make a life-changing difference to cancer patients. For instance, some open-access tools to be developed for decision makers in European countries can be applied on pricing and reimbursement.
Impact of the project:
The project outcomes will help for instance cancer patients to get better access to newest pharmaceuticals and innovative technologies throughout Europe and beyond.
Funding instrument Circular Bio-based Europe (CBE)
Spinverse’s role
Spinverse funding experts supported the consortium in its successful funding proposal process. Spinverse also contributed to the process in mapping the stakeholders in value chain, and contacted and motivated them to join the consortium.
As we had another funding application process going on for us, the support from Spinverse was indispensable during the application process and the Grant Agreement Preparation phase. An external consultant like Spinverse was able to provide us with essential expertise on such a complex process and complemented our somewhat scarce resources, whilst helping us reach the successful outcome.
Supporting the UN Sustainable Development Goals
We share what we learn
Read our latest news on our references
